Literature DB >> 18221427

Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator).

Bruce Buckingham, Dongyuan Xing, Stu Weinzimer, Rosanna Fiallo-Scharer, Craig Kollman, Nelly Mauras, Eva Tsalikian, William Tamborlane, Tim Wysocki, Katrina Ruedy, Roy Beck.   

Abstract

BACKGROUND: There are no published guidelines for use of real-time continuous glucose monitoring data by a patient; we therefore developed the DirecNet Applied Treatment Algorithm (DATA). The DATA provides algorithms for making diabetes management decisions using glucose values: (i) in real time which include the direction and rate of change of glucose levels, and (ii) retrospectively based on downloaded sensor data.
OBJECTIVE: To evaluate the use and effectiveness of the DATA in children with diabetes using a real-time continuous glucose sensor (the FreeStyle Navigator).
SUBJECTS: Thirty children and adolescents (mean +/- standard deviation age = 11.2 +/- 4.1 yr) receiving insulin pump therapy.
METHODS: Subjects were instructed on use of the DATA and were asked to download their Navigator weekly to review glucose patterns. An Algorithm Satisfaction Questionnaire was completed at 3, 7, and 13 wk.
RESULTS: At 13 wk, all of the subjects and all but one parent thought that the DATA gave good, clear directions for insulin dosing, and thought the guidelines improved their postprandial glucose levels. In responding to alarms, 86% of patients used the DATA at least 50% of the time at 3 wk, and 59% reported doing so at 13 wk. Similar results were seen in using the DATA to adjust premeal bolus doses of insulin.
CONCLUSIONS: These results show the feasibility of implementing the DATA when real-time continuous glucose monitoring is initiated and support its use in future clinical trials of real-time continuous glucose monitoring.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18221427      PMCID: PMC2390770          DOI: 10.1111/j.1399-5448.2007.00301.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  11 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

Review 2.  The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change.

Authors:  Dace L Trence; Janet L Kelly; Irl B Hirsch
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

3.  Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring.

Authors:  Dorothee Deiss; Jan Bolinder; Jean-Pierre Riveline; Tadej Battelino; Emanuele Bosi; Nadia Tubiana-Rufi; David Kerr; Moshe Phillip
Journal:  Diabetes Care       Date:  2006-12       Impact factor: 19.112

4.  Continuous glucose monitoring in children with type 1 diabetes.

Authors:  Bruce Buckingham; Roy W Beck; William V Tamborlane; Dongyuan Xing; Craig Kollman; Rosanna Fiallo-Scharer; Nelly Mauras; Katrina J Ruedy; Michael Tansey; Stuart A Weinzimer; Tim Wysocki
Journal:  J Pediatr       Date:  2007-08-24       Impact factor: 4.406

5.  Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation.

Authors:  Paul C Davidson; R Dennis Steed; Bruce W Bode
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

6.  Improved diabetes control by using 'close adjustment algorithms'.

Authors:  Kenichi Miyako; Ryuichi Kuromaru; Hitoshi Kohno; Toshiro Hara
Journal:  Pediatr Int       Date:  2004-12       Impact factor: 1.524

7.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.

Authors:  Anthony P Furnary; Guangqiang Gao; Gary L Grunkemeier; YingXing Wu; Kathryn J Zerr; Stephen O Bookin; H Storm Floten; Albert Starr
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

8.  Algorithms for adjustment of insulin dosage by patients who monitor blood glucose.

Authors:  J S Skyler; D L Skyler; D E Seigler; M J O'Sullivan
Journal:  Diabetes Care       Date:  1981 Mar-Apr       Impact factor: 19.112

9.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.

Authors:  K Malmberg; L Rydén; S Efendic; J Herlitz; P Nicol; A Waldenström; H Wedel; L Welin
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094

10.  How to compare adequacy of algorithms to control blood glucose in the intensive care unit?

Authors:  Greet Van den Berghe
Journal:  Crit Care       Date:  2004-03-23       Impact factor: 9.097

View more
  43 in total

Review 1.  Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems.

Authors:  Tandy Aye; Jen Block; Bruce Buckingham
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

2.  Safety of using real-time sensor glucose values for treatment decisions in adolescents with poorly controlled type 1 diabetes mellitus: a pilot study.

Authors:  Larry A Fox; Emilie Balkman; Kim Englert; Jobayer Hossain; Nelly Mauras
Journal:  Pediatr Diabetes       Date:  2016-07-20       Impact factor: 4.866

Review 3.  A tale of two compartments: interstitial versus blood glucose monitoring.

Authors:  Eda Cengiz; William V Tamborlane
Journal:  Diabetes Technol Ther       Date:  2009-06       Impact factor: 6.118

4.  Clinical overview of continuous glucose monitoring.

Authors:  Bruce Buckingham
Journal:  J Diabetes Sci Technol       Date:  2008-03

5.  Real-life utilization of real-time continuous glucose monitoring: the complete picture.

Authors:  Neesha Ramchandani; Sandeep Arya; Svetlana Ten; Sonal Bhandari
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

6.  Continuous glucose monitoring: the experience of women with type 2 diabetes.

Authors:  Cynthia Fritschi; Laurie Quinn; Sue Penckofer; Patricia M Surdyk
Journal:  Diabetes Educ       Date:  2009-12-16       Impact factor: 2.140

7.  Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial.

Authors:  Alicia J Jenkins; Balasubramanium Krishnamurthy; James D Best; Fergus J Cameron; Peter G Colman; Steven Farish; Peter S Hamblin; Michele A O'Connell; Christine Rodda; Kevin Rowley; Helena Teede; David N O'Neal
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 17.152

8.  Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial.

Authors: 
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

9.  The effect of continuous glucose monitoring in well-controlled type 1 diabetes.

Authors:  Roy W Beck; Irl B Hirsch; Lori Laffel; William V Tamborlane; Bruce W Bode; Bruce Buckingham; Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart A Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  Diabetes Care       Date:  2009-05-08       Impact factor: 19.112

10.  Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.

Authors:  Roy W Beck; Bruce Buckingham; Kellee Miller; Howard Wolpert; Dongyuan Xing; Jennifer M Block; H Peter Chase; Irl Hirsch; Craig Kollman; Lori Laffel; Jean M Lawrence; Kerry Milaszewski; Katrina J Ruedy; William V Tamborlane
Journal:  Diabetes Care       Date:  2009-08-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.